The Indiana Myeloma Registry

Last updated: April 30, 2025
Sponsor: Indiana University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Multiple Myeloma

Cancer

Leukemia

Treatment

This is a non-interventional trial

Clinical Study ID

NCT03616483
IUSCC-0661
  • Ages > 18
  • All Genders

Study Summary

This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Male or female patients ≥ 18 years of age at the time of informed consent

  2. Has been diagnosed with or is suspected to have one of the following:

  3. Monoclonal Gammopathy of Undetermined Significance (MGUS)

  4. Smoldering Multiple Myeloma

  5. Multiple Myeloma

  6. Bony or Soft Tissue Plasmacytoma

  7. Primary Amyloidosis

Exclusion

Exclusion Criteria:

< 18 years of age

Have not been diagnosed with one of the following:

Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis

Study Design

Total Participants: 2500
Treatment Group(s): 1
Primary Treatment: This is a non-interventional trial
Phase:
Study Start date:
June 18, 2018
Estimated Completion Date:
June 30, 2028

Connect with a study center

  • Indiana University Simon Cancer Center

    Indianapolis, Indiana 46202
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.